Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Palo Alto Biotechnology is a high-tech enterprise focused on the research, development, and production of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). As a subsidiary of the California-based Palo Alto Biotechnology, the company serves as a key manufacturing and R&D hub, providing CRO and CMO services to the global life sciences industry. Their technical core competencies include asymmetric synthesis, heterocyclic chemistry, and the production of complex chiral building blocks. The company operates a large-scale production base in Ma'anshan, Anhui, which is equipped to handle custom synthesis from milligram to metric ton scales. By integrating US-based management with Chinese manufacturing efficiency, they support drug development programs across various therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Palo Alto.